Markus Raderer
Impact in
- Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment
- Oncology top 0.2%
- Viral-associated cancers and disorders
- Lung Cancer Research Studies
Papers in
-
- Lymphoma Diagnosis and Treatment 148
- Oncology 112
- Viral-associated cancers and disorders 24
- Lung Cancer Research Studies 23
- Colorectal Cancer Treatments and Studies 20
- Co-authors
- Andreas Chott (66 shared papers)Michael Hejna (42 shared papers)Berthold Streubel (34 shared papers)Werner Scheithauer (43 shared papers)Barbara Kiesewetter (87 shared papers)Stefan Wöhrer (28 shared papers)Gabriela Kornek (34 shared papers)Christoph Zielinski (26 shared papers)
- Journals
- Annals of Oncology (35 papers)Journal of Clinical Oncology (26 papers)Blood (14 papers)Hematological Oncology (12 papers)Oncology (11 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Markus Raderer
315 papers receiving 12.2k citations
Markus Raderer's Hit Papers
Peers
Comparison fields: 5 of 129
- Pathology and Forensic Medicine 5.4k
- Oncology 4.8k
- Neurology 1.9k
- Genetics 1.3k
- Gastroenterology 458
Countries citing papers authored by Markus Raderer
This map shows the geographic impact of Markus Raderer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Raderer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Raderer more than expected).
Fields of papers citing papers by Markus Raderer
This network shows the impact of papers produced by Markus Raderer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Raderer. The network helps show where Markus Raderer may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Raderer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 327 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors Hit paper breakdown → | 2014 | 1349 |
| 2 | 2003 | 371 | |
| 3 | 2004 | 303 | |
| 4 | 2005 | 287 | |
| 5 | 2011 | 260 | |
| 6 | 2005 | 214 | |
| 7 | 1999 | 211 | |
| 8 | 1993 | 206 | |
| 9 | 1996 | 200 | |
| 10 | 2020 | 199 | |
| 11 | 2015 | 177 | |
| 12 | 2016 | 176 | |
| 13 | 2011 | 159 | |
| 14 | 2001 | 157 | |
| 15 | 2002 | 156 | |
| 16 | 2013 | 152 | |
| 17 | 2004 | 151 | |
| 18 | 2003 | 147 | |
| 19 | 2002 | 133 | |
| 20 | 2006 | 133 |
About Markus Raderer
Markus Raderer is a scholar working on Pathology and Forensic Medicine, Oncology, Pulmonary and Respiratory Medicine, Epidemiology and Surgery, having authored 327 papers that have together received 12.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (148 papers), Neuroendocrine Tumor Research Advances (49 papers), Chronic Lymphocytic Leukemia Research (33 papers), Gastric Cancer Management and Outcomes (25 papers), Viral-associated cancers and disorders (24 papers), Lung Cancer Research Studies (23 papers), Colorectal Cancer Treatments and Studies (20 papers) and Neuroblastoma Research and Treatments (19 papers). The work is most often cited by research in Pathology and Forensic Medicine (5.4k citations), Oncology (4.8k citations), Neurology (1.9k citations), Genetics (1.3k citations) and Gastroenterology (458 citations). Markus Raderer has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Andreas Chott, Michael Hejna, Berthold Streubel, Werner Scheithauer, Barbara Kiesewetter, Stefan Wöhrer, Gabriela Kornek, Christoph Zielinski, Andrea Lamprecht and Johannes Drach. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Blood, Hematological Oncology and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.